GALAGEN INC
10-Q, EX-27, 2000-08-14
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: GALAGEN INC, 10-Q, 2000-08-14
Next: PATTERSON ENERGY INC, 10-Q, 2000-08-14



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM SIX MONTHS
ENDED JUNE 30, 2000
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                         196,395
<SECURITIES>                                 1,195,238
<RECEIVABLES>                                  120,399
<ALLOWANCES>                                    18,188
<INVENTORY>                                    143,244
<CURRENT-ASSETS>                             2,082,207
<PP&E>                                         693,776
<DEPRECIATION>                                 465,701
<TOTAL-ASSETS>                               2,860,156
<CURRENT-LIABILITIES>                          506,093
<BONDS>                                              0
                                0
                                          0
<COMMON>                                       105,184
<OTHER-SE>                                   2,203,879
<TOTAL-LIABILITY-AND-EQUITY>                 2,860,156
<SALES>                                          6,459
<TOTAL-REVENUES>                               270,916
<CGS>                                            2,086
<TOTAL-COSTS>                                    2,086
<OTHER-EXPENSES>                             2,533,604
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                            (2,196,257)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (2,196,257)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (2,196,257)
<EPS-BASIC>                                      (.21)
<EPS-DILUTED>                                    (.21)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission